Level D· Scientific groundwork from lab and animal studiesNarrative ReviewEurope PMCOpen access

The role of nucleus pulposus progenitor cells in intervertebral disc degeneration and regeneration

Wang P., Yao Y., Chen X., Luo W., Li H., Wang D.

Narrative Review on Back Pain, Disc Degeneration, published in J Orthop Surg Res (2025) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Narrative Review
Journal
J Orthop Surg Res (2025)
Reported sample size
—
Source database
Europe PMC
PMID
41185036
PMCID
PMC12581458
DOI
10.1186/s13018-025-06319-5
Citations
1

Abstract (original English)

Intervertebral disc degeneration (IDD) is a significant public health issue, commonly associated with symptoms such as low back pain (LBP), and poses a substantial burden on both society and affected families. The pathogenesis of IDD primarily involves the depletion and impaired function of nucleus pulposus (NP) cells, as well as alterations in the extracellular matrix (ECM) composition. Current clinical management strategies, including conservative and surgical treatments, aim primarily to alleviate symptoms rather than reverse the pathological process or promote structural regeneration of the intervertebral disc (IVD). In recent years, studies have identified the presence of nucleus pulposus progenitor cells (NPPCs) within the NP region and characterized specific surface markers associated with these cells. Due to their ability to adapt to the harsh, nutrient-poor IVD microenvironr potential to effectively differentiate into NP-like cells, NPPCs have emerged as a promising candidate for cell-based regenerative therapies aimed at IVD repair. A deeper understanding of the biological properties and regulatory mechanisms of NPPCs is crucial for advancing their therapeutic application. This review summarizes current knowledge on NPPCs, including their characteristics, pathological alterations and associated signaling pathways during disc degeneration, and recent advances in NPPC-b

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is a narrative review: it collects no new patient data and does not systematically appraise evidence quality.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence
Stem CellsAnimalsHumansStem Cell TransplantationRegenerationIntervertebral DiscIntervertebral Disc DegenerationNucleus Pulposus

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research